GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 151 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $393,000 | -57.7% | 27,701 | -56.2% | 0.00% | -60.0% |
Q2 2020 | $930,000 | -29.7% | 63,229 | -80.3% | 0.01% | -41.2% |
Q1 2020 | $1,322,000 | +12.1% | 320,912 | +30.9% | 0.02% | +41.7% |
Q4 2019 | $1,179,000 | +141.1% | 245,118 | +204.0% | 0.01% | +100.0% |
Q3 2019 | $489,000 | -52.2% | 80,627 | -61.7% | 0.01% | -66.7% |
Q4 2018 | $1,022,000 | -26.9% | 210,270 | +10.5% | 0.02% | -10.0% |
Q3 2018 | $1,398,000 | +26.5% | 190,270 | +9.8% | 0.02% | +17.6% |
Q2 2018 | $1,105,000 | -4.0% | 173,247 | -18.1% | 0.02% | -10.5% |
Q1 2018 | $1,151,000 | +8.8% | 211,664 | -16.6% | 0.02% | 0.0% |
Q4 2017 | $1,058,000 | – | 253,700 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|